Skip to main content
Top
Published in: Inflammation Research 9/2008

01-09-2008

Signal pathway involved in inhibition by lipoxin A4 of production of interleukins induced in endothelial cells by lipopolysaccharide

Authors: Sheng-Hua Wu, M.D., P.-Y. Liao, L. Dong, Z.-Q. Chen

Published in: Inflammation Research | Issue 9/2008

Login to get access
Metadata
Title
Signal pathway involved in inhibition by lipoxin A4 of production of interleukins induced in endothelial cells by lipopolysaccharide
Authors
Sheng-Hua Wu, M.D.
P.-Y. Liao
L. Dong
Z.-Q. Chen
Publication date
01-09-2008
Publisher
SP Birkhäuser Verlag Basel
Published in
Inflammation Research / Issue 9/2008
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-008-7147-1

Other articles of this Issue 9/2008

Inflammation Research 9/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine